Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Angiognese Tumoral
Carlos
Angiognese x Vasculognese
Vasculognese: Angiognese:
Formao de novos vasos a partir de clulas totipotentes. Brotamento de novos capilares a partir de vasos sangu neos pr!e"istentes.
At um passado recente, acreditava-se que a vasculognese s acontecia no perodo pr-natal e que, a partir do nascimento, a nica maneira de neovascularizao seria por brotamento (angiognese).
#rocesso controlado$ atravs de um e%uil brio entre &atores pr'!angiognicos e anti! angiognicos
Bruce R. (etter$ )*he scienti&ic contributions o& +. ,udah Fol-man to cancer research.$ Nature Reviews ancer, vol. /$ pp. 012!0314 566/.
Angiognese Tumoral
7!5mm8:
)9...: dist;ncia m<"ima atravs da %ual o"ignio e nutrientes podem prontamente se di&undir.. de 5mm8 =ip'"ia> !rincipal "atil#o da an"io"$nese.
Alm
e multiplicao celular 9mutagnese e mitognese: #roli&erao descontrolada 9neoplasia: tumoral atravs dos 'rgos
% nvel de vascularizao dos tumores
?isseminao
Terapias an i!angiognicas
A
maioria dos atuais agentes %uimioteraputicos anti!cancer genos utiliEados na pr<tica cl nica$ alveFam todas as clulas %ue se dividem indiscriminadamente A&eitos Adversos em terapias anti!angiognicas$ principalmente voltadas na inibio do VAGF A&ic<cia Comprovada
#es%uisas
CJBKLMJ:
*erapias Combinadas
"eferncias:
Robert C. @erbel$ )RevieD article: *umor angiogenesis.$ (#e New )n"land *ournal %+ ,edicine$ vol. N3/$ pp. 56NO!561O4 566/. Poshia-i @ubota$ )*umor angiogenesis and anti!angiogenic *herapQ.$ enter +or -nte"rated ,edical Researc#, .c#ool o+ ,edicine, /eio 0niversit1, (o21o, *apan3 5675. ,. Fol-man$ )*umor angiogenesis:
+. +ansur
'omponen es da (ia
+olculas ligadas H membrana Receptores: &o ch )$ Rotch 5$ Rotch N$ &o ch * Bigantes: +agged )$ ,agged 5$ ?ll5$ ?ll5$ Dll* AnEimas proteol ticas *ACA 9s tio C5: Gamma!secretase 9s tio CN: ?om nio intracelular Rotch 9RSC?: Fator transcricional CCB e +A+B
Fig. 7. *he Rotch signaling cascade. *he Rotch receptors 9Rotch7!1: are single!pass transmembrene proteins that are activated bQ the ?elta!li-e and ,agged &amilies o& membrane!bound ligands e"pressed on adFacent cells. Snteraction Dith ligands leads to tDo additional proteolQtic cleavages 9TA'# and g!secre ase comple": that liberate the &o ch in racellular domain ,&-'D. &rom the plasma membrane. *he RSC? translocates to the nucleus$ Dhere it &orms a comple" Dith the ?RA binding pro ein 'S/. Co!activators$ such as MAM/$ are recruited to the RSC?TCCB comple"$ leading to the transcriptional activation o& Rotch target genes. Rotch receptors can be post! translationallQ modulated bQ glQcosQlation$ Dhich are mediated bQ the enEQmes o& the glQcosQltrans&erase Fringe and J!&ucosQl trans&erase 7 9J!Fut:$ and phosphorQlation. Sn addition$ Rotch can be regulated bQ di&&erent AN ligases to undergo ubi%uitination and subse%uent proteolQsis or endocQtosis. From )Rotch signaling: Amerging molecular targets &or cancer therapQ. Bing Pin a$ Jmaida C. VelaE%ueE a$b$
(hao!,un Biu a$b.
Clula da ponta 9UtipV: direciona migrao do broto angiognico com e"presso de ?ll1 por ativao do VAGF$ bFGF e =SF7!a4 Clula!ei"o 9Ustal-V: recebe sinal do ?ll1 pelo receptor Rotch4 Reduo da sensibilidade a VAGF4 +odulao da rami&icao vascular4
0igure 12?ll1 and ,agged7 shoD antagonistic &unction during sprouting angiogenesis. *ipWstal- cell selection is mediated via ?ll1WRotch lateral inhibition betDeen the ACs that constitute the vasculature$ resulting in the tQpical salt!and!pepper distribution o& tip cells along the vascular endothelium. 9 A: For a detailed e"planation about ?ll1WRotch lateral inhibition see Figure 1. 98: Genetic or pharmacological inhibition o& ?ll1 deregulates the tipWstal- selection process4 dramaticallQ increases the number o& tip cells$ the number o& sprouts and branching$ resulting in a hQperdense and interconnected ple"us. 9 : *he opposite observation has been made a&ter ,agged7 inhibition in phQsiological and pathological angiogenesis$ as ,agged7 antagoniEes reciprocal ?ll1!mediated Rotch activation &rom the stalto the tip cell. From http:WWperspectivesinmedicine.orgWcontentWNW7Wa66030OWF3.e"pansion.html
Via Dll*3&o ch
?iminuio Regulao Bimitao Controle
da rami&icao
JrganiEao
#s udos
#romoo da neoangiognese tumoral diretamente via Rotch: Am clulas de carcinoma epiderm'ide de cabea e pescoo 9=RCCC:
alta e"presso de ,agged 74 aumento dos capilares tumorais4
Fig. N. #otential cancer therapeutics bQ targeting Rotch signaling. *hese include decoQ Rotch ligand 9soluble ?ll1:$ disruption o& tDo proteolQtic cleavages bQ *ACA inhibitor and GCSs$ gene silencing bQ siRRAs$ miRRAs$ histone chaperon and polQhomeotic 9#=: techni%ues$ and transcriptional regulation 9?R!+A+B7:. From )Rotch signaling: Amerging molecular targets &or cancer therapQ. Bing Pin a$ Jmaida C. VelaE%ueE
a$b$ (hao!,un Biu a$b.
5S- 9inibidor gamma!secretase: blo%ueio de Rotch 7$ 5 e 1 reduo da proli&erao de ACs reduo do crescimento do tumor
&o ch ) deco6 9receptor antagonista solZvel de Rotch 7: blo%ueio da sinaliEao Rotch via ligantes ?ll7$ ?ll1 e ,agged 7
Fig. 5. *Do anti!tumor angiogenesis models. 9A: ReutraliEing VAGF!VAGFR signaling bQ anti!VAGF monoclonal antibodies 9bevaciEumabWavastin: inhibits tumor vessel &ormation and reduces tumor siEe. ,B. An agoni$ing Dll*!&o ch signaling 76 ei her an i! Dll* an i7odies or solu7le Dll* paradoxicall6 promo es 7lood (essel forma ion 7u inhi7i s umor gro8 h2 "educed umor gro8 h is resul ed from poor perfusion of ne8l6 formed capillaries2 From )Rotch signaling: Amerging molecular targets &or cancer therapQ. Bing Pin a$
"eferncias:
, ?u&raine$ P Funahashi$ , @itaFeDs-i Jncogene 9566/: Rotch signaling regulates tumor angiogenesis bQ diverse mechanisms. Rature 52: 37N5T37N2.
Bing Pin$ Jmaida C. VelaE%ueE$ (hao!,un Biu 95676: Rotch signaling: Amerging molecular targets &or cancer therapQ. Biochemical #harmacologQ /6: 0O6T267. Roguera!*roise S$ ?alQ C$ #apadopoulos R,$ CoetEee C$ Boland #$ Gale R\ et al. 95660: Bloc-ade o& ?ll1 inhibits tumour groDth bQ promoting non!productive angiogenesis. Rature 111: 76N5T76N2.
RidgDaQ ,$ (hang G$ \u P$ CtaDic-i C$ Biang \C$ ChantherQ P et al. 95660: Snhibition o& ?ll1 signalling inhibits tumour groDth bQ deregulating angiogenesis. Rature 111: 76/NT 76/2. Aasia J. Rehman and Cun!Pu \ang 95660: Rotch signaling in the regulation o& tumor angiogenesis. *RAR?C in Cell BiologQ Vol.70 Ro.0
Ra%uel Blanco and =olger Gerhardt 95675: 5)9: and Notc# in (ip and .tal2 ell .election, #ublish in Advance 76.7767Wcshperspect.a66030O.
@umar$ Abbas$ Fausto$ Aster 95676: Robins X Cotran #atologia Bases #atol'gicas das ?oenas$ Alsevier /Y edio.
V#50
+ariana Astuto
^ual
Angiognese Como
9 :ue ; o V#50?
J
VAGF uma glicoprote na sinaliEadora. stica da &am lia dom nio VAGF
Caracter
9 :ue ; o V#50?
?om
nio VAGF composto do n< de cis ina com oi o res4duos in(arian es de cis e4na envolvidos em pon es de dissulfe o inter e intramoleculares em uma ponta de um plano central conservado de 1 pontas com cada mon_mero %ue se dimeriEa de maneira paralela$ com orientao lateral.
9 :ue ; o V#50?
VAGF A
Pulmo "im 'ora%o 5l=ndula Adrenal
VAGF ?
VAGF A
#SGF
'ora%o Pulmo M>sculo #s:uel; ico -n es ino delg2 '<lon +un o ao V#50 ' impor an e para desen(ol(er pulmo em7rion?rio /igado ao
Semelhan e a%o mas com diferen%a de empo de a%o e cons i ui% o 7io:u4mica
Vascular
endothelial groDth &actor 9VAGF: um importante indu or de angiognese e linfoangiognese por causa da sua espeficidade mi ognica para c;lulas endo eliais2
A-t:
+igrao a partir da medula 'ssea
VAGFR!5W@?RWFl-!7
VAGFR!N
Reuropilina!7
regio e"tracelular
?om nio transmembrana ?om nio tirosina %uinase intracelular
VAGFR!7 e VAGFR!5 so e"pressos predominantemente por clulas do endotlio vascular. VAGFR!7 and VAGFR!5 em outras clulas %ue no seFam endoteliais: Clulas tumorais$ onde h< tambm alta liberao de VAGF Clulas musculares lisas Clulas beta pancre<ticas
de Crescimento e Citocinas:
#romove a mitose das clulas endoteliais e seu crescimento. A liberao de molculas angiognicas9e.g.$ bFGF$ #AF$ VAGF!A$ and VAGFC: Regulao positiva dos sistemas proteol ticos Aumento da transcrio do gene VAGFR!5 *RF!` aumenta a transcrio de neuro&ilina!7.
hormonal
Astr'genos
*estosterona
Angiognese Tumoral
Angiognese Tumoral
#?GF =SFs
Snibidores SB!7
beta
J VAGF uma glicoprote na sinaliEadora. VAGF A$ C e A so os mais importantes na angiognese tumoral J receptor VAGF 7 tem mais a&inidade com VAFG mas o tipo 5 %ue o mais potente *umores %ue secretam VAGF tem maior tendncia a se maligniEarem e disseminarem met<stases Snibio seletiva de VAGF e inibio de molculas %ue estimulam a e"presso de VAGF so promissoras contra o c;ncer
"eferncias:
Vascular
Andothelial GroDth Factor and Angiogenesis ARR =JABAR$ BAR* BAR?KP*$ +AR*SR C. =SG=BAP$ =ARC \SB?SARC$ ABBAR *. VAR JJC*ARJ+$ AR? ARRC* A. ?A BRKS,R BaboratorQ o& A"perimental JncologQ$ KniversitQ =ospital Gasthuisberg$ Catholic KniversitQ o& Beuven$ Beuven$ Belgium 9A.=.$ B.B.$A.*.V.J.$ A.A.?.B.:4 and ?epartment o& Cancer +edicine$
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
A TIE(d) Balance in Tumor Angiogenesis - Winston S.N. Shim , Ivy A.W. o and !hili"
Angiopoie ina ! )
Cecretada principalmente por clulas tumorais e pericitos Formam mult meros %ue se ligam ao receptor *SA!5 induEindo a sua &os&orilao e sinaliEao intra! celular. A&eitos:
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
Angiopoie ina!C
#roduEida principalmente pelas clulas endoteliais4 Ativao dos receptores *SA!5 por ARG!5 no completamente entendida e parece ser controversa.#odendo atuar como um agonista ou antagonista do receptor. A&eitos:
Ao anti!apopt'tica d Brotamento ?estacamento das clulas perivasculares
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
"ecep or T-#!C
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hi
"eferncias:
A *SA9d: Balance in *umor Angiogenesis ! \inston C.R. Chim$ SvQ A.\. =o and #hilip A.=. \ong *he Comple" Role o& Angiopoietin!5 in the Angiopoietin T *ie Cignaling #athDaQ Gavin *hurston and Christopher ?alQ Ss Angiopoietin!5 RecessarQ &or the Snitiation o& *umor Angiogenesis] ,uha Baureen$ PuFi GunFi and @ari Alitalo Ctructural basis &or angiopoietin!7!mediated signaling initiation. Pu I$ Ceegar *C$ ?alton AC$ *Evet-ova!Robev ?$ Goldgur P$ RaFashan-ar @R$
CchDengber Gasparini
Camada interna dos vasos sangu neos Barreira com permeabilidade seletiva Funfes metab'licas e sintticas AstabiliEao
9u ros Mecanismos
Angiopoietinas
9receptores (ie:
Snterleucina!/
*GF!beta
FGF
Mol;culas de Adeso
,!. Adeso
a clulas do sistema imune ,D. Fuga imunol'gica ,D. #rogresso tumoral a clulas pr'!in&lamat'rias ,D. Angiognese tumoral
,D. Adeso
Terapias An i!angiognicas
+todos
anti!endoteliais
Resistncia =eterogeneidade
Rovos &ocos
b
"eferncias:
g7h ABABBJF: A<elo++=s linical %ncolo"1$ 1th ed. CopQright c 566/ Churchill Bivingstone$ an imprint o& Alsevier Snc.
g5h RJBBSRC4 C*ARBAP$ B.4 CJ*RAR4 RA+CS$ C. !at#olo"ic 8asis o+ 4isease. /Y edio. Filadl&ia: Caunders$ an imprint o& Alseviers Snc$ 566/. 7136 p.
gNh BAS P$ C=AR P$ BSK I=$ (=ARG P$ (ARG P$ BSK PF. Snterleu-in!/ Snduces the Andothelial Cell +igration through the Activation o& #hosphoinositide N!@inase! Rac7WRhoA #athDaQ. -nt * 8iol .ci 56774 290::2/5!2O7. doi:76.2736WiFbs.2.2/5. http:WW DDD.iFbs.comWv62p62/5.htm
g1h PK I$ CAAGAR *C$ ?AB*JR AC$ *(VA*@JVA!RJBAV ?$ GJB?GKR P$ RA,AC=AR@AR @R$ RS@JBJV ?B$ BAR*JR \A. Ctructural basis &or angiopoietin!7! mediated signaling initiation. !roc Natl Acad .ci 0 . A. >?@A Apr A?4 77697/::2563!76. doi: 76.762NWpnas.7570/O6776. Apub 567N Apr 70. http :WWDDD.ncbi.nlm.nih.govWpubmedW5N3O527/W
"eferncias:
g3h CK+#SJ BA$ RSBAP ,*$ ?AR?S@ A. Cells in &ocus: endothelial cell. -nt * 8ioc#em ell 8iol. >??> 4ec4N1975::736/!75. http:WW DDD.ncbi.nlm.nih.govWpubmedW75N2O526W
g0h =AR(JG B.4 #ABBA*!+ARP C.4 BRS**JR G.4 =AR*(JKBA@SC B.4 (AC=ARP S.C. VAGF Binding to Reuropilin!7 9RR#7: is Assential &or VAGF Ctimulation o& Andothelial Cell +igration$ Comple" Formation betDeen RR#7 and VAGFR5 and Cignalling via FA@ *Qr162 #hosphorQlation. ,ol. 8iol. ell *une B, >?@@ mbc.A6O!75!7607. http:WW DDD.molbiolcell.orgWcontentWearlQW5677W60W6/Wmbc.A6O!75!7607.&ull.pd&
g2h \ABC=A *A$ CASR*!GARSA( +$ +A=ARA, ACR$ CA@SPA+A A$ +AB?JRA?J AA$ A* AB. 9566O: *GF!a Ss Re%uired &or Vascular Barrier Function$ Andothelial Curvival and =omeostasis o& the Adult +icrovasculature. #BoC JRA 191:: e371O. doi:76.7N27WFournal.pone.666371O http:WW DDD.plosone.orgWarticleWin&oiNAdoii5F76.7N27i5FFournal.pone.666371O
"eferncias:
g/h \AKG= ?. ,. ,.4 \SBCJR C.4 *he Snterleu-in!/ #athDaQ in Cancer. lin ancer Res Novem<er @, >??B 714 02N3. jhttp:WWclincancerres.aacrFournals.orgWcontentW71W57W02N3.&ull k
gOh =ARBAR* C#$ C=AKRG ,P$ C*ASRSAR ?P. ?etermination o& endothelial stal- versus tip cell potential during angiogenesis bQ =5.6!li-e homeobo"!7. urr 8iol. >?@> %ct C45597O::72/O!O1. doi: 76.7670WF.cub.5675.62.6N2. Apub 5675 Aug 5N. http:WW DDD.ncbi.nlm.nih.govWpubmedW55O57N03
g76h ?K?BAP A.C. )*umor Andothelial Cells.. #ublished in Advance Jctober 7/$ 5677$ doi: 76.7767Wcshperspect.a6603N0. CopQright c 5675 Cold Cpring =arbor BaboratorQ #ress http:WW perspectivesinmedicine.orgWcontentW5WNWa6603N0.&ull]sidlO/b216&5!/baO!1d05!//57!e1Oe0b5b/N
g77h BBARCJ R.4 GAR=AR?* =. )VAGF and Rotch in *ip and Ctal- Cell Celection.. #ublished in Advance Jctober 7O$ 5675$ doi: 76.7767Wcshperspect.a66030O CopQright c
PD50 E 050
*haiane
Varela B. Cabral
por cadeias polipept dicas A$ B$ C e ? %ue &ormam homod meros #?GF!AA$ BB$ CC$ ?? e o heterod mero #?GF!AB. biol'gica ligada a dois receptores de tirosina!%uinase #?GF!` e a 9#?GF! R` e #?GF!Ra:
Ao
http:WW
gallus.reactome.orgWcgi!binWeventbroDser]?Bltestmgallusmreactomemreleasem5m mQisamXS?l7/02O2X
#ar<crino
do de
vaso
#roli&erao
e"presso de &atores
Sinali$a%o Au <crina
Gliomas C;ncer
+alignos
de +ama
*GF!a
Carcomas
sis
?ermato&ibrossarcoma
#rotuberante 9 ?FC#: sinal ativado por mutafes nos ligantes ou receptores +iel'ide
Beucemia
Sinali$a%o Par?crina
Recrutamento
Reo!angiognese Cuporte
Aumento
0am4lia 050
5N
FGF!7 FGF
Ao
receptores
http:WWDDD.nature.comWnrcWFournalWv76Wn5W&igmtabWnrc52/6mF7.html
0un%@es de 050
Crescimento
*umoral Celular
?i&erenciao
de &erimentos
na s ntese de plasminognio
Angiognese!7050
050 e Angiognese
=SF!7` em normo"ia Kbi%uitinado =SF!7` em hip'"ia niveis aumentados associao com =SF!7a no nZcleo induEem e"presso dos &atores como VAGF e FGF FGF estimula angiognese na presena de anti! VAGF Snibidor de FGF 9BRSVARSB: em tumores %ue e"pressam resistncia a anti!VAGF
"eferncias:
@un!\ei Biu$ Bo =u$ and Chi!Puan Cheng. #latelet!derived groDth &actor signaling in human malignancies. Chinese ,ournal o& Cancer$ KniversitQ o& #ittsburgh Cancer Snstitute$ #ittsburgh$ KCA. N69O::3/7!1. Cep. 5677. Guo #$ =u B$ Gu \$ Iu B$ \ang ?$ =uang =,$ Cavenee \@$ Cheng CP. #latelet!derived groDth &actor!B enhances glioma angiogenesis bQ stimulating vascular endothelial groDth &actor e"pression in tumor endothelia and bQ promoting pericQte recruitment. *he American ,ournal o& #athologQ. ?epartment o& #athologQ$ KniversitQ o& #ittsburgh Cancer Snstitute$ #ittsburgh$ #ennsQlvania$ KCA. Vol 705$ nn 1. Apr. 566N. \JBFRA+ C.+. ?A+#@A and RJBAR? (S##AB.A Rovel ?ual VAGF!R5WbFGF!R Snhibitor. Snternational ,ournal o& Cancer Research and *reatment. Riesa$ GermanQ. Vol N6 Rn 77. Rov. 5676. CK(SGAR$ Cueli. Angiognese em Reoplasias Apiteliais Corticais Renais: estudo de 17 casos. Co #aulo. F+KC#. 5665. emjhttp:WWbdtd.&amerp.brWtdembuscaWar%uivo.php]codAr%uivol21k acesso em 50 set. 567N. Bruno Graa$ Carla Bunet$ Ana Co&ia Coelho$ Gisela +onteiro$ #aulo Freire$ Andreia Cpeidel$ Bina Carvalho. Acta +dica #ortuguesa. Angiognese e Cancro$ da biopatologia H teraputica. Faculdade de +edicina de Coimbra. Coimbra. 72. 20!ON. 5661 Fabiana =enri%ues +achado de +elo$ +ara de CouEa ,un%ueira e Roger Chamas$ em j http:WWDDD.dire"lim.&m.usp.brWdoDnloadWmimc.pd&k acesso em 50 set. 567N.
Cilva
T50!
A"iste
trs iso&ormas T *GF beta S$ *GF beta SS e *GF beta SSS com seus receptores *bRS ! membrana$ *bRSS! intra celular e *bRSSS.
Atua
SnduE a parada do ciclo celular na transio de G7! C. #ode levar a clula H apoptose por inibio de Bcl5 por VAGF e VAGFR5. Clulas F< carcinognicas tm mudanas na transduo do sinal da *GF beta.
T50! na Angiognese
Ras clulas tumorais h< altas concentrafes de VAGF 9&ator de crescimento vascular endotelial:$ VAGFR5 e *GF beta$ pois no h< aumento de apoptose de clulas endoteliais. Ro se sabe o mecanismo e"ato %ue o VAGFR5 e VAGF ativam o *GF beta para desencadear a angiognese. V<rios e"perimentos indicam %ue esse um evento C+A? dependente.
T50! na Me ?s ase
Regula
o aumento da e"presso de laminina$ integrina e &ibronectina e bai"a e"presso de A!caderina. a aumento de metaloproteinases 9++#:. a e"presso colagenase!N. de plasmina e
Regula
SnduE
genes
da
"eferncias:
C=ARGGARG BS$ BAJ^SARG GKJ$ CAR+ABJ BARRABAK$ AR? C=AR* @K+AR. )Angiogenesis in Breast Cancer: *he Role o& *rans&orming GroDth Factor b and C?763. dispon vel em http:WWDDD.periodicos.capes.gov.brW #eter Carmeliet $ Ra-esh @. ,ain. )Angiogenesis in cancer and other diseases. dispon vel em http:WWlin-.periodicos.capes.gov.br.eE/N.periodicos.capes.gov.brW Rapoleone Ferrara $ Robert C. @erbel. )Angiogenesis as a therapeutic target. dispon vel em http:WWlin-.periodicos.capes.gov.br.eE/N.periodicos.capes.gov.brW Abhi- BandQopadhQaQ$ Pong (hu7$ ChaEli R +ali-$ ,eoreQ @reisberg5$ +ichael G Brattain5$ Augene A Cprague$ ,ian Buo$ Fernando BoppeE! Casillas$ B!( Cun )A"tracellular domain o& *GFb tQpe SSS receptor inhibits angiogenesis and tumor groDth in human cancer cells. dispon vel em http:WWlin-.periodicos.capes.gov.br.eE/N.periodicos.capes.gov.brW
"eferncias:
Cimona
Cerratq$ Francesca +argheri$ +arco #ucci$ Anna Rita Cantelmo$ Rosaria Cammarota$ ,avier ?otor$ Francisco Borrars!Cuesta$ Gabriella Fibbi$ Adriana Albini$ +ario ?el Rosso. )*GFb7 antagonistic peptides inhibit *GFb7! dependent angiogenesis. dispon vel em http:WWDDD.Fournals.elsevier.comWbiochemi cal!pharmacologQ Abul @. 4 FAKC*J$ Relson4
ABBAC$